Vulnerability · Published Sep 6, 2024 · Assigned by mitre
CVE-2024-44837
Medium 5.4
In plain English
A medium-severity cross-site scripting in the affected software. Proof-of-concept exploit code is public. The chance it is exploited in the next 30 days is estimated at 0.3% (higher than 24% of all known vulnerabilities).
Severity (CVSS 3.1)5.4Medium
Exploit odds (30 days)0.3%top 75.9% of all CVEs
Exploited in the wildNo reportsCISA SSVC: poc
Attack toolingNoneno public tooling known
Official description
A cross-site scripting (XSS) vulnerability in the component \bean\Manager.java of Drug v1.0 allows attackers to execute arbitrary web scripts or HTML via a crafted payload injected into the user parameter.
Affected products (as reported)
Weakness: CWE-79 · Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N